- Published
- 09 August 2021
- Letter
Towards a European strategy to address the COVID-19 pandemic
- Authors
-
- Source
- The Lancet
Abstract
Reduction of COVID-19 incidence across Europe in the early spring months of 2021 led to substantial relaxation of restrictions in summer, despite the emergence and spread of the more transmissible SARS-CoV-2 delta variant. As expected, this relaxation led to a renewed increase in incidence. How should Europe act, what strategies should it adopt, and what specific risks should it consider moving forward? These questions become even more pressing, since emerging data indicates the delta variant is more infectious and partially evades immune response. Europe needs a coherent and effective strategy before schools fully reopen and the transmission of SARS-CoV-2 further increases due to seasonality in autumn.
Rights
This content is not covered by the Open Government Licence. Please see source record or item for information on rights and permissions.
Cite as
Priesemann, V., Balling, R., Bauer, S., Beutels, P., Calero Valdez, A., Cuschieri, S., Czypionka, T., Dumpis, U., Glaab, E., Grill, E., Hotulainen, P., Iftekhar, E., Krutzinna, J., Lionis, C., Machado, H., Martins, C., McKee, M., Pavlakis, G., Perc, M., Petelos, E., Pickersgill, M., Prainsack, B., Rocklöv, J., Schernhammer, E., Szczurek, E., Tsiodras, S., Van Gucht, S. & Willeit, P. 2021, 'Towards a European strategy to address the COVID-19 pandemic', The Lancet, 398(10303), pp. 838-839. https://doi.org/10.1016/S0140-6736(21)01808-0